glp 1 antidepressant Glucagon-like Peptide-1 receptor agonists as emerging therapeutics in bipolar disorder: a narrative review of preclinical and clinical evidence

Frontiers Unlocking the potential of GLP 1 receptor agonists in ocular therapeutics: from molecular pathways to clinical impact GLP 1 receptor agonists are increasingly used to treat type 2 diabetes and obesity, and trials have shown reductions in cardiovascular risk and slowing of kidney failure. Adverse events are mostly gastrointestinal. GLP 1 medications are changing the landscape of weight management. But there's a trade off that doesn't get enough attention, and it matters more than most people realize. Up to 40% of the weight GLP 1 medications like Ozempic, Wegovy and Mounjaro are changing diabetes and weight management, but they aren't recommended during pregnancy or while nursing. The current recommendation is to stop before conception and discuss Multiple target tissue effects of GLP 1 analogues on non alcoholic fatty liver disease (NAFLD) and non alcoholic steatohepatitis (NASH) ScienceDirect Ozempic, Victoza, Trulicity and More: what are GLP 1 drugs and how do they work? Skin Grip